0	10	Expression	expression	NN
11	13	of	of	IN
14	17	Th1	th1	NN
18	21	and	and	CC
22	25	Th2	th2	NN
26	30	type	type	NN
31	40	cytokines	cytokine	NNS
41	51	responding	respond	VBG
52	54	to	to	TO
55	60	HBsAg	hbsag	NN
61	64	and	and	CC
65	70	HBxAg	hbxag	NN
71	73	in	in	IN
74	81	chronic	chronic	JJ
82	91	hepatitis	hepatitis	NNP
92	93	B	B	NNP
94	102	patients	patient	NNS
102	103	.	.	.

105	108	The	the	DT
109	117	cytokine	cytokine	NN
118	125	pattern	pattern	NN
126	128	on	on	IN
129	134	viral	viral	JJ
135	142	antigen	antigen	NN
143	154	recognition	recognition	NN
155	157	is	be	VBZ
158	166	believed	believe	VBN
167	169	to	to	TO
170	175	exert	exert	VB
176	177	a	a	DT
178	186	profound	profound	JJ
187	196	influence	influence	NN
197	199	on	on	IN
200	203	the	the	DT
204	214	resolution	resolution	NN
215	217	of	of	IN
218	223	viral	viral	JJ
224	234	infections	infection	NNS
235	238	and	and	CC
239	244	viral	viral	JJ
245	254	clearance	clearance	NN
254	255	.	.	.

256	260	This	this	DT
261	266	study	study	NN
267	270	was	be	VBD
271	280	initiated	initiate	VBN
281	283	to	to	TO
284	295	investigate	investigate	VB
296	303	whether	whether	IN
304	305	a	a	DT
306	314	cytokine	cytokine	NN
315	324	imbalance	imbalance	NN
325	333	oriented	orient	VBN
334	340	toward	toward	IN
341	344	Th2	th2	NN
345	349	type	type	NN
350	358	response	response	NN
359	364	plays	play	VBZ
365	366	a	a	DT
367	371	role	role	NN
372	374	in	in	IN
375	382	chronic	chronic	JJ
383	392	hepatitis	hepatitis	NNP
393	395	B.	B.	NNP
396	404	Cytokine	Cytokine	NNP
405	413	profiles	profile	NNS
414	416	of	of	IN
417	427	peripheral	peripheral	JJ
428	433	blood	blood	NN
434	445	mononuclear	mononuclear	JJ
446	451	cells	cell	NNS
452	462	associated	associate	VBN
463	467	with	with	IN
468	475	chronic	chronic	JJ
476	485	hepatitis	hepatitis	NNP
486	487	B	B	NNP
488	492	were	be	VBD
493	501	analysed	analyse	VBN
502	504	by	by	IN
505	511	RT-PCR	RT-PCR	NNP
511	512	.	.	.

513	517	Upon	upon	IN
518	523	HBsAg	hbsag	NN
524	535	stimulation	stimulation	NN
535	536	,	,	,
537	547	expression	expression	NN
548	550	of	of	IN
551	560	IFN-gamma	IFN-gamma	NNP
560	561	,	,	,
562	566	IL-2	IL-2	NNP
566	567	,	,	,
568	572	IL-4	il-4	NN
572	573	,	,	,
574	577	and	and	CC
578	583	IL-10	IL-10	NNP
584	587	was	be	VBD
588	596	detected	detect	VBN
597	599	in	in	IN
600	602	41	41	CD
602	603	%	%	NN
603	604	,	,	,
605	606	8	8	CD
606	607	%	%	NN
607	608	,	,	,
609	611	41	41	CD
611	612	%	%	NN
612	613	,	,	,
614	617	and	and	CC
618	620	50	50	CD
620	621	%	%	NN
622	624	of	of	IN
625	628	the	the	DT
629	637	patients	patient	NNS
637	638	,	,	,
639	651	respectively	respectively	RB
651	652	.	.	.

653	658	Among	among	IN
659	664	these	these	DT
665	674	cytokines	cytokine	NNS
674	675	,	,	,
676	679	the	the	DT
680	690	expression	expression	NN
691	693	of	of	IN
694	703	IFN-gamma	IFN-gamma	NNP
704	707	was	be	VBD
708	718	associated	associate	VBN
719	723	with	with	IN
724	728	high	high	JJ
729	735	levels	level	NNS
736	738	of	of	IN
739	744	serum	serum	NN
745	752	AST/ALT	ast/alt	NN
752	753	.	.	.

754	761	However	however	RB
761	762	,	,	,
763	765	we	we	PRP
766	771	could	could	MD
772	775	not	not	RB
776	781	prove	prove	VB
782	786	that	that	IN
787	790	Th2	th2	NN
791	795	type	type	NN
796	805	cytokines	cytokine	NNS
806	809	had	have	VBD
810	811	a	a	DT
812	822	protective	protective	JJ
823	829	effect	effect	NN
830	832	on	on	IN
833	844	hepatocytes	hepatocyte	NNS
844	845	.	.	.

846	850	Upon	upon	IN
851	856	HBxAg	hbxag	NN
857	868	stimulation	stimulation	NN
868	869	,	,	,
870	875	there	there	EX
876	879	was	be	VBD
880	882	no	no	DT
883	895	recognizable	recognizable	JJ
896	907	association	association	NN
908	910	of	of	IN
911	919	cytokine	cytokine	NN
920	928	patterns	pattern	NNS
929	933	with	with	IN
934	941	AST/ALT	AST/ALT	NNP
942	948	levels	level	NNS
948	949	.	.	.

950	952	In	in	IN
953	963	conclusion	conclusion	NN
963	964	,	,	,
965	975	production	production	NN
976	978	of	of	IN
979	980	a	a	DT
981	984	Th1	th1	NN
985	993	cytokine	cytokine	NN
993	994	,	,	,
995	1004	IFN-gamma	IFN-gamma	NNP
1004	1005	,	,	,
1006	1008	by	by	IN
1009	1023	HBsAg-reactive	hbsag-reactive	JJ
1024	1029	cells	cell	NNS
1030	1033	was	be	VBD
1034	1044	associated	associate	VBN
1045	1049	with	with	IN
1050	1060	hepatocyte	hepatocyte	NN
1061	1067	damage	damage	NN
1068	1070	in	in	IN
1071	1078	chronic	chronic	JJ
1079	1088	hepatitis	hepatitis	NNP
1089	1090	B	B	NNP
1090	1091	,	,	,
1092	1097	while	while	IN
1098	1100	no	no	DT
1101	1114	counteracting	counteract	VBG
1115	1121	effect	effect	NN
1122	1124	of	of	IN
1125	1128	Th2	th2	NN
1129	1138	cytokines	cytokine	NNS
1139	1147	produced	produce	VBN
1148	1150	by	by	IN
1151	1156	those	those	DT
1157	1162	cells	cell	NNS
1163	1166	was	be	VBD
1167	1175	observed	observe	VBN
1175	1176	.	.	.